Specialists, not generalists
Monoclonal antibodies are our only business. That focus means every reagent gets our full attention to quality, specificity and reproducibility.
A focused catalog of high-performance monoclonal antibodies for food-safety diagnostics — allergens, mycotoxins and pesticides. Built to perform in real food matrices, on your ELISA and lateral-flow platforms.

What we do
Monoclonal antibodies are all we do. We don't make kits or other reagents — our entire focus is developing and producing monoclonal antibodies of the highest possible quality, optimized to perform in real, complex food matrices and to integrate seamlessly into ELISA and lateral-flow tests.
The problem we solve
Diagnostic teams lose months chasing reagents that look right on paper but fail in the matrix. We close that gap.
Monoclonal antibodies are our only business. That focus means every reagent gets our full attention to quality, specificity and reproducibility.
Optimized for real food matrices and for ELISA and lateral-flow platforms — not repurposed research-grade antibodies that fail when it matters.
Rigorous quality control and batch-to-batch consistency, so your assay performs the same way every time.
Deep hybridoma and immunoassay experience, based in the EU, working directly with your team.
Let's talk
Whether you're developing an ELISA, a lateral-flow test or a custom food-safety assay, tell us what you're trying to detect and where your current reagent is falling short.
Many antibodies look promising in buffer. The real test starts when they meet the food matrix.
If you are developing a diagnostic assay for allergens, mycotoxins, pesticides or another food-safety target, send us a few details. We'll review your message and get back to you directly.
No generic sales flow. No automated pitch. Just a direct technical conversation.
European expertise · Direct line to the scientist · Built for real diagnostic development
Technical notes
Occasional short notes on monoclonal antibodies for real food-safety assays: matrix effects, ELISA and lateral-flow development, antibody selection, reproducibility and new target availability.